Spread of carbapenem-resistant Klebsiella pneumoniae in a tertiary hospital in Sao Paulo, Brazil

Journal of Hospital Infection

Volumn 79, Issue 2, 2011, Pages 182-183

  Pereira, G H ^a   Garcia, D O ^b   Mostardeiro, M ^a   Ogassavara, C T ^b   Levin, A S ^c  

^a HOSPITAL BRIGADEIRO   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CARBAPENEM; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFOTAXIME PLUS CLAVULANIC ACID; CEFTAZIDIME; CLAVULANIC ACID; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BRAZIL; CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE; CHILD; CLINICAL ARTICLE; EPIDEMIC; EPSILOMETER TEST; FEMALE; GENOTYPE; HUMAN; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTCOME ASSESSMENT; PRESCHOOL CHILD; SCHOOL CHILD; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BRAZIL; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; GENOTYPE; HOSPITALS, TEACHING; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; YOUNG ADULT;

EID: 80052268852     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2011.05.023     Document Type: Letter

References (8)

1. Maltezou H.C. Metallo-beta-lactamases in Gram-negative bacteria: introducing the era of pan-resistance?. Int J Antimicrob Agents 2009, 33:405e1-405e7.
2. Performance standards for antimicrobial susceptibility testing 2010, Clinical and Laboratory Standards Institute, Twentieth informational supplement. CLSI document M100-S20, Clinical and Laboratory Standards Institute, Wayne, PA.
3. Performance standards for antimicrobial susceptibility testing 2010, Clinical Laboratory Standards Institute, Twentieth informational supplement. Update M100-S20-U, Clinical Laboratory Standards Institute, Wayne, PA.
4. Rasheed J.K., Biddle J.W., Anderson K.F., et al. Detection of the Klebsiella pneumoniae carbapenemase type 2 carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid. J Clin Microbiol 2008, 46:2066-2069.
5. Gautom R.K. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other Gram negative organisms in 1 day. J Clin Microbiol 1997, 35:2977-2980.
6. Lee J., Patel G., Huprikar S., Calfee D.P., Jenkins S.G. Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection. J Clin Microbiol 2009, 47:1611-1612.
7. Falagas M.E., Rafailidis P.I., Matthaiou D.K. Resistance to polymyxins: mechanisms, frequency and treatment options. Drug Resist Updat 2010, 13:132-138.
8. Abboud C.S., Bergamasco M.D., Doi A.D., et al. First report of investigation of an outbreak due to carbapenemase-producing Klebsiella pneumoniae (KPC) in a tertiary Brazilian hospital, with extension to a patient of the community. J Infect Prev 2011, 12:150-153.